Utility of determining autoantibodies to M-type phospholipase A2 receptor in diagnosing primary membranous nephropathy: An ideal setting

Utility of determining autoantibodies to M-type phospholipase A2 receptor in diagnosing primary membranous nephropathy: An ideal setting

Bibliographic Details
Main Authors:	R Ramachandran, V Kumar, N Singh, M Kataruka, M Rathi, H S Kohli, V Jha, K L Gupta
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2017-01-01
Series:	Indian Journal of Nephrology
Online Access:	http://www.indianjnephrol.org/article.asp?issn=0971-4065;year=2017;volume=27;issue=5;spage=413;epage=415;aulast=Ramachandran

Similar Items

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
by: Yun Jung Oh, et al.
Published: (2013-01-01)

The role of Anti-phospholipase A2 Receptor Autoantibody as a biomarker of Idiopathic Membranous Nephropathy
by: Rodrigo Manuel Brás Batata
Published: (2021)

A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
by: Elion Hoxha, et al.
Published: (2021-04-01)

CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
by: Raja Ramachandran, et al.
Published: (2017-01-01)

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy
by: Vladimir Tesar, et al.
Published: (2021-03-01)

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
by: Cornelia Dähnrich, et al.
Published: (2020-02-01)

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
by: Sangho Lee
Published: (2018-09-01)

Study of hypothalamic pituitary adrenal axis in patients of membranous nephropathy receiving modified Ponticelli regimen
by: R Ramachandran, et al.
Published: (2015-01-01)

Phospholipase A2 Receptor Autoantibodies as a Novel Serological Biomarker for Autoimmune Thyroid Disease Associated Nephropathy
by: Biao Huang, et al.
Published: (2020-04-01)

The significance of anti-phospholipase receptor antibodies in a patient with membranous nephropathy
by: Jayaprakash R Dasari, et al.
Published: (2020-01-01)

Association of The Autoantibodies to M-Type Phospholipase A2 Receptor Titer with Clinical Characteristics and Outcome of Patients with Primary Membranous Nephropathy – 5-Year Follow up Study
by: Mario Laganović, et al.
Published: (2021-01-01)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
by: Ning-Xin Xu, et al.
Published: (2017-01-01)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
by: David Mathew, et al.
Published: (2021-09-01)

Current Concepts on Anti-Phospholipase A2 Receptor Antibody in Idiopathic Membranous Nephropathy
by: Hamid Nasri
Published: (2014-04-01)

Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
by: Nicolas Hanset, et al.
Published: (2020-03-01)

Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
by: Liu L, et al.
Published: (2018-05-01)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
by: Mohammad-Reza Ardalan, et al.
Published: (2013-01-01)

Urinary Podocalyxin as a Biomarker to Diagnose Membranous Nephropathy.
by: Takahiro Imaizumi, et al.
Published: (2016-01-01)

Two-Year Follow-up Study of Membranous Nephropathy Treated With Tacrolimus and Corticosteroids Versus Cyclical Corticosteroids and Cyclophosphamide
by: Raja Ramachandran, et al.
Published: (2017-07-01)

Significance of anti-phospholipase A2 receptor antibodies in membranous nephropathy after renal transplantation
by: Praveen Kumar Etta, et al.
Published: (2020-01-01)

Antiphospholipase A2 Receptor Autoantibodies: A Step Forward in the Management of Primary Membranous Nephropathy
by: Bogdan Obrisca, et al.
Published: (2015-01-01)

Plasma exchange in Immunoglobulin A nephropathy with thrombotic microangiopathy and acute cortical necrosis
by: P Doddi, et al.
Published: (2016-01-01)

Temporal Association Between PLA2R Antibodies and Clinical Outcomes in Primary Membranous Nephropathy
by: R. Ramachandran, et al.
Published: (2018-01-01)

Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
by: Marion Delafosse, et al.
Published: (2020-09-01)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
by: Maxime Teisseyre, et al.
Published: (2020-05-01)

Association of <it>phospholipase A2 receptor 1 </it>polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan
by: Liao Wen-Ling, et al.
Published: (2010-10-01)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
by: Eun Joo Song, et al.
Published: (2018-09-01)

Correlation and discrepancy of phospholipase A2 receptor staining in membranous nephropathy in paraffin-embedded kidney biopsies
by: Nasar Yousuf Alwahaibi, et al.
Published: (2018-01-01)

Diagnostic Test Accuracy of Serum Anti-PLA2R Autoantibodies and Glomerular PLA2R Antigen for Diagnosing Idiopathic Membranous Nephropathy: An Updated Meta-Analysis
by: Weiying Li, et al.
Published: (2018-04-01)

Membranous nephropathy with collapse: Poor prognosis
by: Joyita Bharati, et al.
Published: (2020-01-01)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
by: Chao Li, et al.
Published: (2018-12-01)

Anti-Phospholipase A2 Receptor Antibodies in Biopsy-Proven Idiopathic Membranous Nephropathy: A Report from the Pakistani Population
by: Haneef, M., et al.
Published: (2022)

Antiphospholipase A2 Receptor Autoantibodies: A Comparison of Three Different Immunoassays for the Diagnosis of Idiopathic Membranous Nephropathy
by: Astrid Behnert, et al.
Published: (2014-01-01)

POS-149 PREVALENCE OF ANTI-PLA2R ANTIBODIES AND ITS CLINICAL UTILITY IN PATIENTS OF MEMBRANOUS NEPHROPATHY- INDIAN EXPERIENCE
by: P. JHA, et al.
Published: (2021-04-01)

Rituximab in Membranous Nephropathy
by: Philipp Gauckler, et al.
Published: (2021-04-01)

Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
by: Maida Mahmud, et al.
Published: (2019-01-01)

Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics
by: Jing Zhang, et al.
Published: (2020-02-01)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
by: Wenkai Guo, et al.
Published: (2020-02-01)

Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
by: Hong-Rui Dong, et al.
Published: (2016-01-01)

Membranous nephropathy and carbamazepine
by: B Sangeetha, et al.
Published: (2014-01-01)